Author Guidelines

The European Journal of Molecular Pharmacy (EJMP) welcomes the submission of original, high-quality scholarly manuscripts that contribute to the advancement of research, innovation, and practical applications in molecular pharmacy, pharmaceutical sciences, and related scientific fields.

The journal encourages innovative and scientifically rigorous research that enhances understanding in drug development, pharmaceutical technology, molecular therapeutics, pharmacology, medicinal chemistry, nanomedicine, and related areas of pharmaceutical and biomedical research.

Authors are requested to carefully follow the guidelines below to ensure a smooth peer review and publication process.

Scope of the Journal

The European Journal of Molecular Pharmacy (EJMP) publishes scholarly research addressing contemporary developments, theoretical advancements, experimental investigations, and practical applications in molecular pharmacy and pharmaceutical sciences. The journal also welcomes research connecting pharmacy with biotechnology, medicinal chemistry, biomedical sciences, nanotechnology, pharmacokinetics, clinical pharmacy, and related scientific disciplines.

Types of Manuscripts Accepted

The journal accepts the following categories of manuscripts:

  • Original Research Articles
  • Review Articles
  • Case Reports and Case Studies
  • Conceptual and Theoretical Papers
  • Technical and Experimental Reports

All submissions must demonstrate originality, scientific quality,

Manuscript Submission

All manuscripts must be submitted electronically through the journal’s official online submission system.

By submitting a manuscript, authors confirm that:

  • The work is original and has not been previously published.
  • The manuscript is not under consideration by another journal or publisher.
  • All listed authors have made substantial scholarly contributions to the work.
  • All authors have reviewed and approved the final version of the manuscript prior to submission.
  • The manuscript complies with the journal’s ethical and publication policies.

Paper Format Template

Authors are advised to prepare their manuscript according to the following structure:

Title of the Paper
Author(s) Name(s) and Affiliation(s)
Abstract
(150–250 words)
Keywords
(4–6 keywords)
Main Sections

  • Introduction
  • Materials and Methods / Methodology
  • Results
  • Discussion
  • Conclusion
  • Acknowledgements (if applicable)
  • Funding Information (if applicable)
  • Conflict of Interest Statement
  • References (APA Style)

Formatting Requirements

  • Font: Times New Roman
  • Font Size: 12 pt (Title: 14 pt bold)
  • Line Spacing: 1.5
  • Margins: 1 inch on all sides
  • Alignment: Justified
  • Page Numbers: Bottom center or bottom right
  • File Format: Microsoft Word (.doc or .docx)

Tables and figures must be clearly numbered and cited within the manuscript text. Figure captions and table titles should be concise, clear, and informative.

Authors are encouraged to ensure that all scientific nomenclature, units, abbreviations, and references are presented accurately and consistently throughout the manuscript.

References and Citation Style

Authors should ensure that all references are accurate, complete, and properly cited within the manuscript. The journal recommends the use of APA style or the journal’s prescribed citation format.

  • Author name(s)
  • Year of publication
  • Title of article/book
  • Journal or publisher information
  • Volume, issue, and page numbers
  • DOI (if available)

Kindly visit publisher website regarding to full information.

Ethical Standards

The European Journal of Molecular Pharmacy (EJMP) follows internationally recognized ethical publishing standards and adheres to the guidelines and best practices recommended by the Committee on Publication Ethics (COPE).

  • Properly cite and acknowledge all sources used in the manuscript.
  • Avoid plagiarism, duplicate publication, data fabrication, and data falsification.
  • Disclose any financial or non-financial conflicts of interest.
  • Provide accurate research data and transparent methodology.
  • Obtain necessary ethical approvals for studies involving humans, animals, or clinical investigations where applicable.
  • Ensure compliance with applicable institutional and international ethical standards.

All submitted manuscripts are subject to plagiarism and similarity screening before entering the peer review process.

Peer Review Process

All submitted manuscripts undergo an initial editorial assessment followed by a double-blind peer review process conducted by qualified experts in the relevant field. The journal evaluates manuscripts based on originality, scientific quality, clarity, relevance, and contribution to the field.

The editorial board reserves the right to accept, reject, or request revisions for submitted manuscripts.

Copyright and Licensing

Authors retain copyright of their published work unless otherwise specified by the journal’s publication policy. Published articles may be distributed under an open-access licensing model to ensure wider dissemination and accessibility of scholarly research.

Contact

For questions regarding manuscript preparation or submission, authors may contact the editorial office through the official journal website or journal email address. Click here...